Literature DB >> 21079598

Molecular probes: Getting lucky in the lysosome.

Ethan D Goddard-Borger, Tom Wennekes, Stephen G Withers.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 21079598     DOI： 10.1038/nchembio.470

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN： 1552-4450            Impact factor:   15.040


× No keyword cloud information.
  9 in total

1.  Imaging of enzyme replacement therapy using PET.

Authors:  Christopher P Phenix; Brian P Rempel; Karen Colobong; Doris J Doudet; Michael J Adam; Lorne A Clarke; Stephen G Withers
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Ultrasensitive in situ visualization of active glucocerebrosidase molecules.

Authors:  Martin D Witte; Wouter W Kallemeijn; Jan Aten; Kah-Yee Li; Anneke Strijland; Wilma E Donker-Koopman; Adrianus M C H van den Nieuwendijk; Boris Bleijlevens; Gertjan Kramer; Bogdan I Florea; Berend Hooibrink; Carla E M Hollak; Roelof Ottenhoff; Rolf G Boot; Gijsbert A van der Marel; Herman S Overkleeft; Johannes M F G Aerts
Journal:  Nat Chem Biol       Date:  2010-10-31       Impact factor: 15.040

3.  The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms.

Authors:  Richard A Steet; Stephen Chung; Brandon Wustman; Allan Powe; Hung Do; Stuart A Kornfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

Review 4.  Pharmacologic chaperoning as a strategy to treat Gaucher disease.

Authors:  Zhanqian Yu; Anu R Sawkar; Jeffery W Kelly
Journal:  FEBS J       Date:  2007-10       Impact factor: 5.542

5.  Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.

Authors:  Hui-Hwa Chang; Naoki Asano; Satoshi Ishii; Yoshitaka Ichikawa; Jian-Qiang Fan
Journal:  FEBS J       Date:  2006-09       Impact factor: 5.542

6.  The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase.

Authors:  Richie Khanna; Elfrida R Benjamin; Lee Pellegrino; Adriane Schilling; Brigitte A Rigat; Rebecca Soska; Hadis Nafar; Brian E Ranes; Jessie Feng; Yi Lun; Allan C Powe; David J Palling; Brandon A Wustman; Raphael Schiffmann; Don J Mahuran; David J Lockhart; Kenneth J Valenzano
Journal:  FEBS J       Date:  2010-02-10       Impact factor: 5.542

7.  Inhibition of glucocerebrosidase and induction of neural abnormality by cyclophellitol in mice.

Authors:  S Atsumi; C Nosaka; H Iinuma; K Umezawa
Journal:  Arch Biochem Biophys       Date:  1992-09       Impact factor: 4.013

Review 8.  Active-site-specific chaperone therapy for Fabry disease. Yin and Yang of enzyme inhibitors.

Authors:  Jian-Qiang Fan; Satoshi Ishii
Journal:  FEBS J       Date:  2007-10       Impact factor: 5.542

Review 9.  Glycosphingolipids--nature, function, and pharmacological modulation.

Authors:  Tom Wennekes; Richard J B H N van den Berg; Rolf G Boot; Gijsbert A van der Marel; Herman S Overkleeft; Johannes M F G Aerts
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336
  9 in total
  1 in total

Review 1.  Plant Glycosides and Glycosidases: A Treasure-Trove for Therapeutics.

Authors:  Kassiani Kytidou; Marta Artola; Herman S Overkleeft; Johannes M F G Aerts
Journal:  Front Plant Sci       Date:  2020-04-07       Impact factor: 5.753
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.